Zobrazeno 1 - 10
of 309
pro vyhledávání: ''
Autor:
Hao Wang, Qiaohua Xie, Cong Cheng, Peng Wang, Liping Lei, ShouZi Hu, Guofang Liu, Huabang Zhou, YouShun Liu, Heping Hu
Publikováno v:
Bulletin du Cancer. 108:931-939
Summary Background Both modified Child-Pugh (MCP) and Albumin-bilirubin (ALBI) grade were reported that simpler, more objective and evidence-based alternative to the Child-Pugh (CP) class for assessing liver function. Aims To investigate whether the
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:783-791
Purpose Autoimmune connective tissue disease (CTD) has historically represented a relative contraindication to breast conservation (BC) among patients with early-stage breast cancer. Controversy exists regarding the use of hypofractionated radiation
Autor:
Chae-Seon Hong, Jee Suk Chang, Jin Sung Kim, Hwa Kyung Byun, Nak Hoon Son, Ye-In Park, Namki Hong, Yong Bae Kim, Jihun Kim, Seo Hee Choi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:462-472
To study the hypothyroidism risk after adjuvant radiation therapy (RT) and the association of different RT targets with hypothyroidism risk.We studied 4073 women treated with adjuvant RT for breast cancer from 2007 to 2016. The primary endpoint was h
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:444-451
Purpose Combined modality therapy (CMT) is standard therapy for early-stage Hodgkin lymphoma (ESHL). We previously reported excellent outcomes with the abbreviated Stanford V regimen. Herein we report updated results with median follow-up >10 years o
Autor:
Ranjit Nair, Chelsea C. Pinnix, Bouthaina S. Dabaja, Loretta J. Nastoupil, Jillian R. Gunther, Sattva S. Neelapu, Paolo Strati, Wenli Dong, Sairah Ahmed, Nathan Fowler, Chul S. Ha, Jason R. Westin, Raphael E Steiner, Ethan P. Damron, Penny Fang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:1414-1420
Purpose We report the long-term results of a prospective trial conducted to determine the efficacy and safety of radiation therapy (RT) alone in treating localized mucosa-associated lymphoid tissue (MALT) lymphoma. Methods and Materials Patients with
Autor:
Sungjune Kim, Kujtim Latifi, Gretchen MacMillan, Trevor Rose, Min-Hsuan Wang, Bradford A. Perez, Theresa A. Boyle, Scott J. Antonia, Jose R. Conejo-Garcia, Ahmad M. Karimi, Austin Lannon, Tawee Tanvetyanon, Jiannong Li, Eric B. Haura, Michael Shafique, Jhanelle E. Gray, Chase Powell, Stephen A. Rosenberg, G. Daniel Grass, Michael J. Schell, Thomas J. Dilling, Ben C. Creelan, Alberto Chiappori, James Saller, Andreas Saltos
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Consolidative thoracic radiation therapy (TRT) has been shown to improve outcomes for patients with extensive stage small cell lung cancer. We hypothesized that the addition of ipilimumab (IPI) and nivolumab (NIVO) after TRT would improve out
Autor:
Wen-Shan Liu, Yaoh-Shiang Lin, Ching-Chih Lee, Kuo-Wang Tsai, Wei-Lun Huang, Ching-Chieh Yang, Bor-Hwang Kang, Yu-Chang Hu, Kuo-Ping Chang, Hsiu-Min Chen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 109:495-504
To compare the treatment outcome and severe late adverse effects (AEs) between conventional volume and dose (CVD) and simultaneously reduced volume and dose (SRVD) of clinical target volume treatments in patients with nasopharyngeal carcinoma.This re
Autor:
Martin Voss, Detlef Imhoff, Jörg Bojunga, Joachim P. Steinbach, Nina von Mettenheim, Marlies Wagner, Katharina J. Wenger, Johannes Rieger, Frank Paulsen, Emmanouil Fokas, Patrick N. Harter, M. Glatzel, Manuela Vetter, Michael W. Ronellenfitsch, Elke Hattingen, Oliver Baehr, Ruediger Gerlach, Claus Rödel, Kea Franz
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:987-995
Purpose ERGO2 is the first randomized clinical trial on a calorically restricted ketogenic diet (KD) and intermittent fasting (KD-IF) in addition to reirradiation for recurrent malignant gliomas. Methods and Materials Fifty patients were randomized 1
Autor:
Sang Hoon Ahn, Beom Kyung Kim, Seung Hoon Beom, Hye Won Lee, Kwang Hyub Han, Do Young Kim, Hwa Kyung Byun, Hye Jin Choi, Jun Yong Park, Seung Up Kim, Jinsil Seong
Publikováno v:
Ann Transl Med
Purpose Although sorafenib as a standard of care for advanced hepatocellular carcinoma (HCC) prolongs overall survival (OS), its efficacy is limited owing to its unsatisfactory objective response and marginal survival benefit. To counter these limita
Autor:
Laura Hughes, Nicholas Counsell, Elizabeth Miles, Yenting Ngai, Virginia Laurence, Susan Harden, David Landau, Zafar Malik, John D. Fenwick, C. Eswar, Paula Wells, William Philip M. Mayles, Laura Farrelly, Marianne Illsley, Nazia Mohammed, Andrew Bates, James Spicer, Angel Garcia-Alonso, Anne Marie Mullin, S. Vivekanandan, Angela Baker
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics
Purpose The IDEAL-CRT phase 1/2 multicenter trial of isotoxically dose-escalated concurrent chemoradiation for stage II/III non-small cell lung cancer investigated two 30-fraction schedules of 5 and 6 weeks’ duration. We report toxicity, tumor resp